United States · 
Who invested in Eikon Therapeutics?
Eikon Therapeutics's investors include General Catalyst, Lux Capital, Foresite Capital, StepStone Group and Alexandria Real Estate Equities.
United States · Series D startup
Who invested in Eikon Therapeutics
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Valuation: $3.2B, 2022
Follow Eikon Therapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$351Mraised across 1 round since 2025, from 1 source
- Latest round
- Series D, $351MFeb 2025
- Investors
- 5
The rounds
- Feb 2025Series D$351M
Reported by Crunchbase NewsSEC filing: $351M sold, first sale Feb 2025
Funding filed with regulators
Eikon Therapeutics filed 4 raises, $1.1B in all. Filings say how much was sold and to how many investors; they never name the investors.
- Feb 2025$351MSEC Form D
- May 2023$141MSEC Form D
- Dec 2021$518MSEC Form D
- May 2021$103MSEC Form D
Founders and team
From Eikon Therapeutics's own website: 7 on the team.
- Roger PerlmutterChief Executive Officer
- Alfred BowieChief Financial Officer
- Barbara HowesChief People Officer
- Ben ThornerChief Business Officer and General Counsel
- Mike KlobucharChief Operating Officer
- Roy BaynesChief Medical Officer
- Russ BermanChief Technology Officer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Eikon Therapeutics
How much has Eikon Therapeutics raised?
Eikon Therapeutics has raised $351M across 1 round since 2025.
When did Eikon Therapeutics last raise?
Eikon Therapeutics's most recent round was a Series D of $351M in Feb 2025.
What was Eikon Therapeutics's biggest round?
Its most recent round, $351M in Feb 2025, is also its largest on record.
Who backed Eikon Therapeutics first?
Eikon Therapeutics's first round on record, in Feb 2025, was backed by General Catalyst, Lux Capital and Foresite Capital and 2 others.
What stage is Eikon Therapeutics at?
Eikon Therapeutics's latest named round is a Series D, in Feb 2025.
Where is Eikon Therapeutics based?
Eikon Therapeutics is based in the United States.
Companies like Eikon Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.